News & Analysis as of

Automation Systems › Trade Secrets › Cybersecurity

Foley & Lardner LLP

AI in Drug Discovery: 2025 Outlook

Foley & Lardner LLP on

Looking forward to the 2025 prediction season, a survey of the emerging AI-powered drug discovery landscape has been making the rounds—and with good reason. The survey, summarized by Stanford’s Chris Bradbury, is likely the...more

Morris, Manning & Martin, LLP

Legal Issues Around AI Are Real. And Complex.

Morris, Manning & Martin, LLP on

Last week I had the pleasure of sitting down and discussing the legal implications of AI with a group of General Counsels. This group of GCs represented companies from the Fortune 100 all the way to mid-size enterprises. That...more

Proskauer Rose LLP

Question of the Week: What do you expect the biggest impacts of Generative AI (GenAI) to be on M&A in the next 12-18 months?

Proskauer Rose LLP on

"I expect to see an increased focus on GenAI-specific inquiries in the due diligence process and corresponding representations and warranties in purchase and merger agreements. Governing legal terms and conditions vary...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide